Sarah A. Frech
Corporate Officer/Principal bij IOMAI CORPORATION
Oorsprong van het eerstegraads netwerk van Sarah A. Frech
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sarah A. Frech via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| VALNEVA | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada. | Medical Distributors | Director/Board Member President | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Valneva USA, Inc. | Director/Board Member Chief Executive Officer | ||
| Atlantic Biotherapies | Chief Executive Officer | ||
| NOVAVAX, INC. | Biotechnology | Director/Board Member | |
| Intercell Austria AG | Corporate Officer/Principal | ||
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member | |
| MAXCYTE, INC. | Biotechnology | Chairman | |
| Chengdu Grimaud Breeding Co. Ltd. | Director/Board Member | ||
| Labyrinth Choir, Inc. | Director/Board Member | ||
| Vivalis Toyama Japan KK | Chairman | ||
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| Smol Therapeutics SAS | Chief Executive Officer | ||
| University of Ottawa | College/University | Masters Business Admin | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Grimaud Deyang Animal Co. Ltd. | Director/Board Member | ||
Pays de la Loire Participations
 Pays de la Loire Participations Investment ManagersFinance Investissement pour le Développement des Entreprises l'Emploi is designed to invest in small and mid cap companies based in the Pays de la Loire region of France. The fund will invest mainly in innovative companies with a profitable track record and help them in their growth by taking minority participation. | Investment Managers | Director/Board Member | |
| University of Vienna | College/University | Graduate Degree | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Boston University | College/University | Doctorate Degree | |
| GE AEROSPACE | Industrial Machinery | Corporate Officer/Principal | |
R.J. Reynolds Tobacco Co.
 R.J. Reynolds Tobacco Co. TobaccoConsumer Non-Durables R.J. Reynolds Tobacco Co. manufactures and markets tobacco products. The firm has tobacco-sheet manufacturing operations and a research-and-development facility in Winston-Salem. Its brands include Camel, Kool, Pall Mall, Winston, Doral, Barclay, Lucky Strike, and Monarch. The company was founded in 1875 and is headquartered in Winston-Salem, NC. | Tobacco | Corporate Officer/Principal | |
Hoechst Corp
 Hoechst Corp Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst Corp is a pharmaceutical concern. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| George Washington University | College/University | Masters Business Admin | |
| Vienna University of Economics & Business | College/University | Doctorate Degree | |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
| HOOKIPA PHARMA INC. | Biotechnology | Director of Finance/CFO | |
| Elatos GmbH | Corporate Officer/Principal | ||
| University of California, Los Angeles | College/University | Masters Business Admin | |
| University of Illinois | College/University | Doctorate Degree | |
Atlanpole Biotherapies
 Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Chairman | |
| University of Michigan | College/University | Undergraduate Degree | |
The National Center for Genome Resources
 The National Center for Genome Resources Miscellaneous Commercial ServicesCommercial Services The National Center for Genome Resources operates as a non-profit research institute for applied software engineering and next-generation sequencing to solve the preeminent challenges of 21st century biology through collaborative research and services. Its capabilities include genome, transcriptome, methylome, ChIP, small RNA, and exome sequencing, with corresponding analytical capabilities. The company is headquartered in Santa Fe, NM. | Miscellaneous Commercial Services | Director/Board Member | |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Glaxo Laboratories Ltd.
 Glaxo Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK. | Medical Distributors | Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 23 |
| Frankrijk | 8 |
| Oostenrijk | 7 |
| Verenigd Koninkrijk | 6 |
| Zweden | 3 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Distribution Services | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 45 |
| Corporate Officer/Principal | 24 |
| Director of Finance/CFO | 12 |
| Chief Executive Officer | 9 |
| Chairman | 8 |
Sterkste connecties
| Insiders | |
|---|---|
| David Lawrence | 29 |
| Franck Grimaud | 22 |
| Thomas Martin Vernon | 13 |
| Richard Douglas | 10 |
| Reinhard Kandera | 10 |
| F. Weller Meyer | 6 |
| Jin Sook Chung | 6 |
| Robert C. Seid | 5 |
| Kai Chen | 4 |
- Beurs
- Insiders
- Sarah A. Frech
- Bedrijfsconnecties
